Since our founding in 2003, NMT has made remarkable progress in bringing to market a comprehensive suite of innovative noninvasive hemodynamic monitoring and assessment tools and solutions that provide both military and civilian medical specialists with real-time situational awareness and critical lifesaving intelligence. In this regard, we are fast approaching full commercialization of cutting edge, innovative products that we believe each hold potential to materially change the universal standard of medical care.
NMT manufactures its patented noninvasive hemodynamic monitors for use across the care continuum. Our clinical and administrative staff collectively has many years of development work in the field of bioimpedance application.
NMT is the only cardioplethsmograph company that incorporates the patented three-dimensional signal averaging into our technology. In addition NMT leads the world in research and development of new and innovative uses for noninvasive hemodynamic monitoring.
NMT truly has no direct competitor. Our products target markets spanning across the care continuum, as opposed to other companies that claim to be a global leader in patient monitoring, yet only cater to a single demographic in the world of healthcare. Our core competencies are many as we consistently learn of new and innovative applications for our technology. NMT views it as our duty and corporate culture to push the boundaries of noninvasive patient monitoring by continually exploring new frontiers in support of our mission.
To save lives by continually advancing the standard for noninvasive patient monitoring across the care continuum, while maximizing clinical, medical, and financial outcomes, and promoting scientific innovation.
Again, welcome to NMT. We sincerely appreciate your interest in our company!